Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Clin Transplant. 2012 Dec 30;27(1):E64–E71. doi: 10.1111/ctr.12054

Table 5.

Change in spirometrically assessed allograft function before and after community acquired respiratory virus (CARV) infection.

Baseline FEV1 Post-Infection FEV1 %Change in FEV1 (Baseline vs. Post) p value (Baseline vs. Post) > 20% FEV1 Decline

All CARVs (n=62) 2.34 ±0.70 2.19 ±0.79 -6.4% 0.07 9 (14.1)
RV Subgroup (n=36) 2.38 ±0.68 2.27 ±0.83 -4.6% 0.37 5 (13.9)
Non-RV Subgroup (n=26) 2.28 ±0.75 2.08 ±0.74 -8.8% 0.047 4 (15.4)

Data presented as mean ±SD, or n(%).